Page last updated: 2024-09-05

sk&f 99085 and phosphatidylcholines

sk&f 99085 has been researched along with phosphatidylcholines in 1 studies

Compound Research Comparison

Studies (sk&f 99085)	Trials (sk&f 99085)	Recent Studies (post-2010) (sk&f 99085)	Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)
15	2	3	32,204	443	5,593

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ebetino, FH; Edwards, CM; Hulley, PA; Roelofs, AJ; Rogers, MJ; Russell, RG	1

Other Studies

1 other study(ies) available for sk&f 99085 and phosphatidylcholines

Article	Year
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Diphosphonates; Down-Regulation; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Multiple Myeloma; Phosphatidylcholines; Protein Prenylation	2007

Article

Year

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Diphosphonates; Down-Regulation; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Multiple Myeloma; Phosphatidylcholines; Protein Prenylation

2007